Preclinical molecule development is a essential step in bringing innovative therapies to patients. Maximizing the performance of these therapies requires rigorous understanding of their pharmacokinetic (PK) and pharmacodynamic (PD) properties. Comprehensive preclinical DMPK services offer a extensive range of assays designed to define the fate and